Abstract
Wnt signalling has an important role in cell fate determination, tissue patterning and tumorigenesis1,2,3,4. Secreted antagonists of Wnt include Frizzled (Fz)-related proteins (FRPs)5,6,7, Cerberus8, Wnt inhibitory factor (WIF)9 and Dickkopf (Dkk)10,11. FRPs, Cerberus and WIF have all been shown to act by binding and sequestering Wnt. We report a novel mechanism of Wnt-signalling inhibition by human Dkk-1. Dkk-1 demonstrated no interaction with Wnt but bound a single cell surface site with high affinity (KD = 0.39 nM). Its receptor was detectable in a complex with a relative molecular mass of 240,000 (Mr 240K) with [125I] Dkk-1 by covalent affinity cross-linking. Wnt signalling through β-catenin is mediated by the Fz receptor12 and a recently identified low-density-lipoprotein-receptor-related co-receptor, LRP6/Arrow13,14,15. Overproduction of the 200K LRP6 protein, but not of Fz, strikingly increased Dkk-1 binding as well as the amount of the 240K cross-linked complex, which was shown to be composed of Dkk-1 and LRP6. Moreover, Dkk-1 function was completely independent of Fz but LRP6 dramatically interfered with the Dkk-1 inhibition of Wnt signalling. Thus, unlike Wnt antagonists, which exert their effects by molecular mimicry of Fz5,6,7 or Wnt sequestration through other mechanisms8,9, Dkk-1 specifically inhibits canonical Wnt signalling by binding to the LRP6 component of the receptor complex.
Similar content being viewed by others
References
Nusse, R. & Varmus, H. E. Cell 69, 1073–1087 (1992).
Cadigan, K. M. & Nusse, R. Genes Dev. 11, 3286–3305 (1997).
Polakis, P. Genes Dev. 14, 1837–1851 (2000).
Bienz, M. & Clevers, H. Cell 103, 311–320 (2000).
Leyns, L., Bouwmeester, T., Kim, S. H., Piccolo, S. & De Robertis, E. M. Cell 88, 747–756 (1997).
Wang, S., Krinks, M., Lin, K., Luyten, F. P. & Moos, M. Jr Cell 88, 757–766 (1997).
Bafico, A. et al. J. Biol. Chem. 274, 16180–16187 (1999).
Piccolo, S. et al. Nature 397, 707–710 (1999).
Hsieh, J. C. et al. Nature 398, 431–436 (1999).
Glinka, A. et al. Nature 391, 357–362 (1998).
Fedi, P. et al. J. Biol. Chem. 274, 19465–19472 (1999).
Bhanot, P. et al. Nature 382, 225–230 (1996).
Wehrli, M. et al. Nature 407, 527–530 (2000).
Pinson, K. I., Brennan, J., Monkley, S., Avery, B. J. & Skarnes, W. C. Nature 407, 535–538 (2000).
Tamai, K. et al. Nature 407, 530–535 (2000).
Dale, T. C. Biochem. J. 329, 209–223 (1998).
Seidensticker, M. J. & Behrens, J. Biochim. Biophys. Acta 1495, 168–182 (2000).
Eastman, Q. & Grosschedl, R. Curr. Opin. Cell Biol. 11, 233–240 (1999).
Boutros, M., Mihaly, J., Bouwmeester, T. & Mlodzik, M. Science 288, 1825–1828 (2000).
Schlessinger, J. Cell 103, 211–225 (2000).
Chan, A. M. et al. Science 254, 1382–1385 (1991).
Hannum, C. H. et al. Nature 343, 336–340 (1990).
Hulsken, J., Birchmeier, W. & Behrens, J. J. Cell Biol. 127, 2061–2069 (1994).
Gazit, A. et al. Oncogene 18, 5959–5966 (1999).
Brown, S. D. et al. Biochem. Biophys. Res. Commun. 248, 879–888 (1998).
Bafico, A., Gazit, A., Wu-Morgan, S. S., Yaniv, A. & Aaronson, S. A. Oncogene 16, 2819–2825 (1998).
Bottaro, D. P. et al. Science 251, 802–804 (1991).
Acknowledgements
This work has been supported by an NCI grant (CA71672-04). We thank F. Hess for generously providing LRP5 and LRP6 cDNAs, and R. Kohansky and T. Moran for helpful advice.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bafico, A., Liu, G., Yaniv, A. et al. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol 3, 683–686 (2001). https://doi.org/10.1038/35083081
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/35083081
- Springer Nature Limited
This article is cited by
-
CDK9 inhibitors downregulate DKK1 expression to suppress the metastatic potential of HCC cells
Genes & Genomics (2023)
-
Circulating cytokines present in multiple myeloma patients inhibit the osteoblastic differentiation of adipose stem cells
Leukemia (2022)
-
WNT/β-catenin Pathway: a Possible Link Between Hypertension and Alzheimer’s Disease
Current Hypertension Reports (2022)
-
RhoA/Rock activation represents a new mechanism for inactivating Wnt/β-catenin signaling in the aging-associated bone loss
Cell Regeneration (2021)
-
Twelve years of GWAS discoveries for osteoporosis and related traits: advances, challenges and applications
Bone Research (2021)